Global Cord Blood (CORBF) Competitors $0.71 0.00 (0.00%) As of 08/1/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock CORBF vs. EHAB, TOI, VMD, XGN, DCGO, EUDA, SERA, QIPT, NAKA, and BNRShould you be buying Global Cord Blood stock or one of its competitors? The main competitors of Global Cord Blood include Enhabit (EHAB), Oncology Institute (TOI), Viemed Healthcare (VMD), Exagen (XGN), DocGo (DCGO), EUDA Health (EUDA), Sera Prognostics (SERA), Quipt Home Medical (QIPT), KindlyMD (NAKA), and Burning Rock Biotech (BNR). These companies are all part of the "healthcare" industry. Global Cord Blood vs. Its Competitors Enhabit Oncology Institute Viemed Healthcare Exagen DocGo EUDA Health Sera Prognostics Quipt Home Medical KindlyMD Burning Rock Biotech Global Cord Blood (NYSE:CORBF) and Enhabit (NYSE:EHAB) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability. Which has more volatility & risk, CORBF or EHAB? Global Cord Blood has a beta of -0.52, meaning that its share price is 152% less volatile than the S&P 500. Comparatively, Enhabit has a beta of 1.68, meaning that its share price is 68% more volatile than the S&P 500. Is CORBF or EHAB more profitable? Global Cord Blood has a net margin of 0.00% compared to Enhabit's net margin of -13.43%. Enhabit's return on equity of 2.02% beat Global Cord Blood's return on equity.Company Net Margins Return on Equity Return on Assets Global Cord BloodN/A N/A N/A Enhabit -13.43%2.02%0.94% Do analysts recommend CORBF or EHAB? Enhabit has a consensus target price of $8.75, suggesting a potential upside of 34.00%. Given Enhabit's stronger consensus rating and higher probable upside, analysts clearly believe Enhabit is more favorable than Global Cord Blood.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Global Cord Blood 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Enhabit 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media prefer CORBF or EHAB? In the previous week, Enhabit had 1 more articles in the media than Global Cord Blood. MarketBeat recorded 1 mentions for Enhabit and 0 mentions for Global Cord Blood. Global Cord Blood's average media sentiment score of 0.00 equaled Enhabit'saverage media sentiment score. Company Overall Sentiment Global Cord Blood Neutral Enhabit Neutral Which has stronger earnings & valuation, CORBF or EHAB? Global Cord Blood has higher earnings, but lower revenue than Enhabit. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlobal Cord Blood$196.12M0.44$79.04MN/AN/AEnhabit$1.03B0.32-$156.20M-$2.77-2.36 SummaryEnhabit beats Global Cord Blood on 8 of the 11 factors compared between the two stocks. Get Global Cord Blood News Delivered to You Automatically Sign up to receive the latest news and ratings for CORBF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CORBF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CORBF vs. The Competition Export to ExcelMetricGlobal Cord Bloodhealth & allied services, not elsewhere classified IndustryMedical SectorNYSE ExchangeMarket Cap$86.30M$64.04M$5.47B$20.63BDividend YieldN/AN/A4.73%3.67%P/E RatioN/A0.5528.8929.01Price / Sales0.440.36371.4465.92Price / Cash1.402.8035.4522.82Price / BookN/A0.118.264.43Net Income$79.04M$43.11M$3.25B$993.74M7 Day PerformanceN/A-3.31%-3.73%-3.39%1 Month Performance-51.03%-39.40%4.28%-2.10%1 Year Performance-52.67%7.18%25.85%10.09% Global Cord Blood Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CORBFGlobal Cord BloodN/A$0.71flatN/AN/A$86.30M$196.12M0.001,200Gap UpEHABEnhabit2.5424 of 5 stars$6.66-2.0%$8.75+31.5%-35.0%$343.83M$1.03B-2.4010,700Upcoming EarningsTOIOncology Institute2.4753 of 5 stars$3.62-4.0%$7.00+93.4%+578.2%$336.41M$403.15M-5.17660Positive NewsGap DownVMDViemed Healthcare2.893 of 5 stars$6.26+0.5%N/A-13.6%$246.23M$224.26M20.871,179News CoveragePositive NewsUpcoming EarningsXGNExagen4.5379 of 5 stars$8.45+14.3%$9.00+6.5%+329.4%$157.41M$55.64M-10.06220Trending NewsEarnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionGap UpHigh Trading VolumeDCGODocGo2.9225 of 5 stars$1.42-4.7%$3.56+150.7%-61.8%$151.96M$520.50M-71.004,407News CoveragePositive NewsUpcoming EarningsEUDAEUDA Health0.9661 of 5 stars$3.28-0.6%N/A-14.6%$122.62M$4.01M0.002SERASera Prognostics0.6744 of 5 stars$2.90-7.6%N/A-67.1%$118.29M$80K-3.09120News CoveragePositive NewsUpcoming EarningsQIPTQuipt Home Medical2.0178 of 5 stars$2.19+2.3%$2.85+30.1%-39.5%$92.97M$245.91M-10.431,200NAKAKindlyMDN/A$8.41-20.6%N/AN/A$77.36M$2.72M-10.92N/AGap DownHigh Trading VolumeBNRBurning Rock Biotech0.7798 of 5 stars$5.81-15.8%N/A-17.0%$74.25M$70.67M-3.071,390 Related Companies and Tools Related Companies EHAB Competitors TOI Competitors VMD Competitors XGN Competitors DCGO Competitors EUDA Competitors SERA Competitors QIPT Competitors NAKA Competitors BNR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CORBF) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Global Cord Blood With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
